March 12, 2020 / 10:50 AM / 19 days ago

BRIEF-Iterum Therapeutics Posts Q4 Loss Per Share Of $1.59

March 12 (Reuters) - Iterum Therapeutics PLC:

* ITERUM THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

* AS OF DECEMBER 31, 2019, ITERUM HAD CASH AND CASH EQUIVALENTS OF $4.8 MILLION

* QTRLY ADJUSTED LOSS PER SHARE OF $1.59

* Q4 EARNINGS PER SHARE VIEW $-1.70 — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below